南京医药(600713.SH)：新工投资集团累计减持“南药转债”110.8万张

Group 1 - The company Nanjing Pharmaceutical (600713.SH) has received a notification from New Investment Group regarding a reduction in holdings [1] - The reduction period for the convertible bonds occurred from September 16, 2025, to October 14, 2025 [1] - New Investment Group has cumulatively reduced its holdings of "Nanjing Pharmaceutical Convertible Bonds" by 1.108 million units, which accounts for 10.25% of the total issuance of the convertible bonds [1]